Antibody Drug Conjugates Market (By Application: Blood Cancer, Breast Cancer, Urothelial Cancer & Bladder Cancer, Others; By Technology: Cleavable Linker, Non- cleavable Linker, Linkerless) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Antibody Drug Conjugates Market, By Application

7.1.  Antibody Drug Conjugates Market, by Application, 2021-2028

7.1.1.    Blood Cancer

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Breast Cancer

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Ovarian Cancer

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    Lung Cancer

7.1.4.1.        Market Revenue and Forecast (2016-2028)

7.1.5.    Brain Tumor

7.1.5.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Antibody Drug Conjugates Market, By Technology

8.1.  Antibody Drug Conjugates Market, By Technology, 2021-2028

8.1.1.    Cleavable Linker

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Non-cleavable Linker

8.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Antibody Drug Conjugates Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Application (2016-2028)

9.1.2.    Market Revenue and Forecast, By Technology (2016-2028)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.1.3.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.1.4.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Application (2016-2028)

9.2.2.    Market Revenue and Forecast, By Technology (2016-2028)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.3.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.4.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.5.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.6.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Application (2016-2028)

9.3.2.    Market Revenue and Forecast, By Technology (2016-2028)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.3.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.4.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.5.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.6.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Application (2016-2028)

9.4.2.    Market Revenue and Forecast, By Technology (2016-2028)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.3.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.4.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.5.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.6.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Application (2016-2028)

9.5.2.    Market Revenue and Forecast, By Technology (2016-2028)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.5.3.2.        Market Revenue and Forecast, By Technology (2016-2028)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.5.4.2.        Market Revenue and Forecast, By Technology (2016-2028)

Chapter 10.  Company Profiles

10.1.              Seattle Genetics, Inc .

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Takeda Pharmaceutical Company Limited

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Pfizer Inc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              F. Hoffmann-La Roche Ltd.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              AbbVie Inc.

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Report Details

  • Report Code:37297
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:August 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers